文献速递脑血管病外科神经重症

蛛网膜下腔出血后血管痉挛的化学血管成形术联合解痉药治疗

Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage.
PubMed 文献 · Acta Neurochir (Wien) · 2017-02-21

意识清醒伴局灶神经功能缺损者临床改善最明显,昏迷患者疗效不确定。

要点

  • 经动脉给予解痉药是治疗血管痉挛安全有效的方法。
  • 对意识清醒伴局灶神经功能缺损的患者疗效最明显。
  • 对昏迷患者,其治疗获益尚不确定。

核心结论

  • 经动脉给予解痉药是治疗血管痉挛安全有效的方法。
  • 该疗法对意识清醒伴局灶神经功能缺损的患者最有效。
  • 对昏迷患者,其治疗获益尚不确定。
  • 病情严重的患者还需使用多模态脑监测等其他诊断工具来补充血管痉挛治疗。

研究设计与样本

  • 28例患者行动脉瘤夹闭术,6例行动脉瘤弹簧圈栓塞术。
  • 解痉药在动脉瘤破裂后第2天至第18天经动脉给予尼莫地平或米利酮。
  • 共实施53次操作。

主要发现

  • 53次操作中,92%的病例造影改善,平均血流速度下降65 cm/s。
  • 操作后监测了脑代谢变化。
  • 意识清醒伴局灶神经功能缺损(失语、偏瘫)的患者即刻临床改善最明显。
  • 总体临床结局(格拉斯哥结局量表,GOS)为:GOS 5(12例)、GOS 4(5例)、GOS 3(5例)、GOS 2(6例)、GOS 1(6例)。

临床怎么用

  • 经动脉给予解痉药是治疗血管痉挛安全有效的方法。
  • 该疗法对意识清醒伴局灶神经功能缺损的患者最有效。
  • 对昏迷患者,其治疗获益尚不确定。
  • 病情严重的患者还需使用多模态脑监测等其他诊断工具来补充血管痉挛治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinically symptomatic vasospasm leading to delayed ischemic neurological deficits occurs in up to 30% of patients with subarachnoid hemorrhage (SAH). Vasospasm can result in a serious decline in clinical conditions of patients with SAH, yet the algorithm for vasospasm treatment and prevention remains unclear. Intra-arterial administration of vasodilators is one of the modalities used for vasospasm therapy. METHODS: Over the last 7 years, we have treated 27 female and 7 male patients with vasospasm using intra-arterial administration of either nimodipine or milrinone; all had suffered aneurysm rupture. Of these patients, 28 were treated surgically (clip), and 6 patients had their aneurysm coiled. Spasmolytics were applied from day 2 to day 18 after rupture. RESULTS: Of the 53 procedures, angiographic improvement was documented in 92% of cases with a mean flow velocity decrease of 65 cm/s. Brain metabolism changes were monitored after the procedure. The highest level of immediate clinical improvement was observed in conscious patients with a focal neurological deficit (aphasia, hemiparesis). Overall clinical outcomes (Glasgow outcome scale, GOS) were as follows: GOS 5 (12 patients), GOS 4 (5 patients), GOS 3 (5 patients), GOS 2 (6 patients), and GOS 1 (6 patients). CONCLUSIONS: Intra-arterial administration of spasmolytics is a safe and potent method of vasospasm treatment. It is most effective when applied to conscious patients with a focal deficit. For unconscious patients, its therapeutic benefits are inconclusive. Patients in severe clinical states would further require use of other diagnostic tools such as multimodal brain monitoring to complement vasospasm therapy.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Hejčl A, Cihlář F, Smolka V, et al. Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage. Acta Neurochir (Wien). 2017. PMID: 28224318. doi:10.1007/s00701-017-3104-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。